Abstract
Fetal alcohol syndrome (FAS) is a pattern of anomalies occurring in children born to alcoholic women. The main features of this pattern are pre and/or postnatal growth retardation, characteristic facial abnormalities, and central nervous system dysfunction, including mental retardation. Since its clinical recognition in 1973 it has progressed from an unrecognized condition to a major public health concern with exaggerated and unfounded claims as to causality and impact. This review summarizes some of the basic facts about fetal alcohol syndrome with respect to terminology, prevalence, and mechanisms, in the context of exposure risk.
Keywords: Threshold, Risk Spectrum Terminology, Prevalence, Fetal Mechanisms, Alcohol Diagnosis, Abuse
Current Pharmaceutical Design
Title: Fetal Alcohol Syndrome: A Cautionary Note
Volume: 12 Issue: 12
Author(s): Ernest L. Abel
Affiliation:
Keywords: Threshold, Risk Spectrum Terminology, Prevalence, Fetal Mechanisms, Alcohol Diagnosis, Abuse
Abstract: Fetal alcohol syndrome (FAS) is a pattern of anomalies occurring in children born to alcoholic women. The main features of this pattern are pre and/or postnatal growth retardation, characteristic facial abnormalities, and central nervous system dysfunction, including mental retardation. Since its clinical recognition in 1973 it has progressed from an unrecognized condition to a major public health concern with exaggerated and unfounded claims as to causality and impact. This review summarizes some of the basic facts about fetal alcohol syndrome with respect to terminology, prevalence, and mechanisms, in the context of exposure risk.
Export Options
About this article
Cite this article as:
Abel L. Ernest, Fetal Alcohol Syndrome: A Cautionary Note, Current Pharmaceutical Design 2006; 12 (12) . https://dx.doi.org/10.2174/138161206776389886
DOI https://dx.doi.org/10.2174/138161206776389886 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases
Current Protein & Peptide Science CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Atypical Presentation Of Anti-Retroviral Therapy Induced Lactic Acidosis as Acute Right Ventricular Failure And Severe Pulmonary Hypertension
New Emirates Medical Journal Local Activation and Systemic Dysregulation of T Lymphocytes in Sjögren’s Syndrome
Current Pharmaceutical Biotechnology The Intestinal Environment in Health and Disease – Recent Insights on the Potential of Intestinal Bacteria to Influence Human Health
Current Pharmaceutical Design Advanced Glycation: A Novel Outlook on Atherosclerosis
Current Pharmaceutical Design Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Nanocarriers for Tracking and Treating Diseases
Current Medicinal Chemistry Recent Advances in Synthesis of PAR Ligands as Therapeutic Strategy for Inflammatory Diseases
Mini-Reviews in Medicinal Chemistry Infection-Associated Biomarkers of Inflammation in Atherosclerosis
Current Pharmaceutical Design New Oral Anticoagulants in Prophylaxis of Venous Thromboembolic Disease in Major Orthopedic Surgery
Cardiovascular & Hematological Disorders-Drug Targets Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature
Current Diabetes Reviews Pyridines and Imidazopyridines with Medicinal Significance
Current Topics in Medicinal Chemistry Genetic Engineering in Allotransplantation of Vascularized Organs
Current Gene Therapy Recent Patents on Oral Combination Drug Delivery and Formulations
Recent Patents on Drug Delivery & Formulation Lipid Nanocarriers and Molecular Targets for Malaria Chemotherapy
Current Drug Targets Extending Life Using Tissue and Organ Replacement
Current Aging Science Molecular Mechanisms Underlying St. Johns Wort Drug Interactions
Current Drug Metabolism Oral Hypoglycemics: A Review of Chemicals Used to Treat Type 2 Diabetes
Current Bioactive Compounds A Review on Development and Characterization of a Cost-effective Targeted Quality-driven Antimalarial Product with an Emphasis on Phytosomes
Current Drug Targets